Back to overview
Manufacturer
Astellas Pharma AG
1
Active shortages
3
Historical
32
Niedrig
0%
No info
Reporting behaviour
Status 1 · Directly reported
1100%
Status 1 = company communicates proactively · Status 4 = no information. A high share of Status 4 raises the Severity Score.
| Product↑ | Status↑ | Days↓ | Score↑ |
|---|---|---|---|
| OMIX OCAS Ret Tabl 0.4 mg 100 Stk | 1 | 341 | 32 |
Data from drugshortage.ch · Score methodology